4.7 Article

The dynamics of quantitative SARS-CoV-2 antispike IgG response to BNT162b2 vaccination

期刊

JOURNAL OF MEDICAL VIROLOGY
卷 93, 期 12, 页码 6813-6817

出版社

WILEY
DOI: 10.1002/jmv.27231

关键词

COVID-19; mRNA vaccine; quantitative antispike RBD IgG; SARS-Cov-2

类别

向作者/读者索取更多资源

This study aimed to investigate the dynamics of SARS-CoV-2 antispike immunoglobulin G (IgG) response in medical staff who received two doses of the BNT162b2 vaccination. Results showed that almost all participants obtained serum antispike RBD IgG 14 days after the first dose of the BNT162b2 vaccine.
Vaccination for SARS-CoV-2 is necessary to overcome coronavirus disease 2019 (COVID-19). However, the time-dependent vaccine-induced immune response is not well understood. This study aimed to investigate the dynamics of SARS-CoV-2 antispike immunoglobulin G (IgG) response. Medical staff participants who received two sequential doses of the BNT162b2 vaccination on days 0 and 21 were recruited prospectively from the Musashino Red Cross Hospital between March and May 2021. The quantitative antispike receptor-binding domain (RBD) IgG antibody responses were measured using the Abbott SARS-CoV-2 IgGII Quant assay (cut off >= 50 AU/ml). A total of 59 participants without past COVID-19 history were continuously tracked with serum samples. The median age was 41 (22-75) years, and 14 participants were male (23.7%). The median antispike RBD IgG and seropositivity rates were 0 (0-31.1) AU/ml, 0.3 (0-39.5) AU/ml, 529.1 (48.3-8711.4) AU/ml, 18,836.9 (742.2-57,260.4) AU/ml, and 0%, 0%, 98.3%, and 100% on days 0, 3, 14, and 28 after the first vaccination, respectively. The antispike RBD IgG levels were significantly increased after day 14 from vaccination (p < 0.001) The BNT162b2 vaccination led almost all participants to obtain serum antispike RBD IgG 14 days after the first dose.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据